Jun 10, 2020
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk
May 26, 2020
DURECT Corporation Announces Positive Topline Data from Phase 1b Study of DUR-928 in NASH
Apr 09, 2020
Natreon's exploratory study highlights benefits of a unique complex of trivalent chromium, shilajit and amla with fish-oil
Mar 30, 2020
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol
Mar 28, 2020
Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
Mar 18, 2020
Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy
Feb 06, 2020
Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart Attack. But is it Enough?
Dec 09, 2019
Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease
Nov 15, 2019
Amgen And The Duke Clinical Research Institute Announce Initiation Of First Large-Scale Registry To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors
Nov 14, 2019
HDL Cholesterol Function Lab Test Offers Novel Insight into Cardiovascular Disease Risk, Reports Quest Diagnostics at American Heart Association 2019 Scientific Sessions
Nov 11, 2019
Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio
Sep 30, 2019
"Good" Cholesterol Counters Atherosclerosis in Mice with Diabetes
Sep 30, 2019
Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag(TM)
Sep 17, 2019
Familial Hypercholesterolemia Patients at High Risk for Cardiovascular Events Despite Treatment
Aug 28, 2019
New Amgen Data To Be Presented At ESC Congress 2019 Highlight Additional Evidence For Repatha® (Evolocumab) Effectiveness In Cardiovascular Disease Across Multiple Patient Groups
Aug 14, 2019
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Jul 23, 2019
Individuals Had More Heart Attacks and Strokes When Cholesterol-lowering Drug Prescription Was Rejected or Unfilled
Jul 18, 2019
HDL Cholesterol Kits Market to Witness an Opportunity Worth US$ 790 Mn by 2029-end | Future Market Insights
Jun 24, 2019
Zora Biosciences: LDL-Cholesterol Does Not Predict Heart Risk Among Heart Patients
Jun 10, 2019
Initial Determination Finds ACON's 3-1 Lipid Panels Infringe PTS Diagnostics' Patents